The Effect on Survival and Mortality of the Highest SUVmax Value on Metastatic Foci in Postoperative Kidney Tumors

dc.contributor.authorKomek, H.
dc.contributor.authorAltindag, S.
dc.contributor.authorCan, C.
dc.contributor.authorAguloglu, N.
dc.contributor.authorMorcali, H.
dc.contributor.authorKepenek, F.
dc.contributor.authorKaraoglan, H.
dc.date.accessioned2024-04-24T17:24:16Z
dc.date.available2024-04-24T17:24:16Z
dc.date.issued2018
dc.departmentDicle Üniversitesien_US
dc.description.abstractObjective: One-third of patients newly diagnosed with a kidney tumor have metachoronous disease, 25-50% have synchronous metastasis, and approximately 30-40% of patients have metastasis at the time of diagnosis. Metastasis mostly occurs in the lungs, regional lymph nodes, bones, and liver. The present study was aimed to determine the effect on mortality the values of standard uptake value (SUV)max measured with positron emission tomography (PET) in metastases of kidney tumors. Material and Methods: A retrospective review was conducted of the files of 77 patients newly diagnosed with kidney tumor and disease staging determined with PET in the Nuclear medicine Department of Saglik Bilimleri University Diyarbakir Gazi Yasargil Training and Research Hospital between August 2007 and April 2012. The gender, age, histological types, metastases, SUVmax values, and dates of death of the patients were recorded in the SPSS software. Results: It was observed that higher SUVmax values indicated a shorter survival time (r = .303) (P = 0.022). Patients with metastasis lived for a shorter period (P < 0.001), particularly those with liver metastasis (r = .515) (P = 0.049). Metastases were most frequently seen in lymph nodes (42.1%); the SUVmax values of lung metastases were higher (P = 0.025) and papillary carcinomas showed higher SUVmax uptake (P = 0.015). Conclusions: In the present study, it was concluded that the higher the SUVmax value the shorter the survival time. The survival time of patients with metastasis was shorter, and this could be estimated through the measured SUVmax values.en_US
dc.identifier.doi10.4103/njcp.njcp_302_16
dc.identifier.endpage169en_US
dc.identifier.issn1119-3077
dc.identifier.issue2en_US
dc.identifier.pmid29465049
dc.identifier.scopus2-s2.0-85042597423
dc.identifier.scopusqualityQ2
dc.identifier.startpage163en_US
dc.identifier.urihttps://doi.org/10.4103/njcp.njcp_302_16
dc.identifier.urihttps://hdl.handle.net/11468/19572
dc.identifier.volume21en_US
dc.identifier.wosWOS:000425783900007
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.publisherWolters Kluwer Medknow Publicationsen_US
dc.relation.ispartofNigerian Journal of Clinical Practice
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectPositron Emission Tomography (Peten_US
dc.subjectCt)en_US
dc.subjectSuvmaxen_US
dc.subjectKidney Tumorsen_US
dc.subjectSurvivalen_US
dc.subjectMetastasisen_US
dc.titleThe Effect on Survival and Mortality of the Highest SUVmax Value on Metastatic Foci in Postoperative Kidney Tumorsen_US
dc.titleThe Effect on Survival and Mortality of the Highest SUVmax Value on Metastatic Foci in Postoperative Kidney Tumors
dc.typeArticleen_US

Dosyalar